{"schema_version":"secwatch.filing_event.v1","accession":"0000856982-26-000007","form_type":"8-K","ticker":"MMSI","cik":"0000856982","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.831842+00:00","generated_at":"2026-05-16T00:59:14.090801+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Merit Medical Q4 revenue $393.9M (+11% YoY); guides FY2026 EPS $4.01-$4.15","bullets":["Q4 revenue $393.9M (+11% YoY); GAAP EPS $0.63 (+37%); Non-GAAP EPS $1.04 (+12%).","FY2025 revenue $1.516B (+12% YoY); GAAP EPS $2.13 (+5%); Non-GAAP EPS $3.83 (+11%).","Q4 Non-GAAP operating margin 21.0% vs 19.6% prior year; Free cash flow $74.0M (+13%).","FY2026 guidance: revenue $1.610-$1.630B (+6-8%); Non-GAAP EPS $4.01-$4.15 (+5-8%).","Constant currency organic revenue grew 7% in both Q4 and FY2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000856982-26-000007","json":"https://secwatch.observer/filing/0000856982-26-000007.json","markdown":"https://secwatch.observer/filing/0000856982-26-000007.md","text":"https://secwatch.observer/filing/0000856982-26-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856982/000085698226000007/0000856982-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856982/000085698226000007/mmsi-20260224x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:59:14.090801+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}